Casey Woodring
Stock Analyst at J.P. Morgan
(3.00)
# 2,628
Out of 4,468 analysts
162
Total ratings
53%
Success rate
3.1%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Rated: Sell | $11 → $12 | $18.25 | -34.25% | 19 | Jul 1, 2026 | |
| ICLR ICON Public Limited Company | Rated: Hold | $130 → $155 | $173.06 | -10.44% | 18 | Jun 25, 2026 | |
| ILMN Illumina | Upgraded: Buy | $125 → $185 | $188.68 | -1.95% | 5 | Jun 10, 2026 | |
| BRKR Bruker | Maintained: Buy | $55 → $65 | $61.64 | +5.45% | 3 | Jun 8, 2026 | |
| TEM Tempus AI | Maintained: Hold | $60 → $50 | $60.27 | -17.04% | 4 | Jun 1, 2026 | |
| A Agilent Technologies | Maintained: Buy | $180 | $130.69 | +37.73% | 4 | May 27, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $17 → $20 | $39.01 | -48.73% | 3 | May 12, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $30 | $25.94 | +15.65% | 1 | May 12, 2026 | |
| DHR Danaher | Reiterated: Buy | $245 | $197.93 | +23.78% | 7 | May 11, 2026 | |
| MTD Mettler-Toledo International | Rated: Hold | $1,413 → $1,200 | $1,308.43 | -8.29% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $265 | $279.32 | -5.13% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $130 → $135 | $167.98 | -19.63% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $30 | $18.30 | +63.93% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $125 | $120.35 | +3.86% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 → $90 | $113.76 | -20.89% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $165 | $142.40 | +15.87% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $330 → $345 | $379.29 | -9.04% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $8 | $10.32 | -22.48% | 2 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $45 | $40.10 | +12.22% | 18 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $710 → $600 | $523.44 | +14.63% | 5 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $190 → $160 | $230.69 | -30.64% | 21 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $17.93 | -10.76% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 | $207.04 | +23.16% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $4.35 | n/a | 5 | Aug 9, 2024 |
QuidelOrtho
Jul 1, 2026
Rated: Sell
Price Target: $11 → $12
Current: $18.25
Upside: -34.25%
ICON Public Limited Company
Jun 25, 2026
Rated: Hold
Price Target: $130 → $155
Current: $173.06
Upside: -10.44%
Illumina
Jun 10, 2026
Upgraded: Buy
Price Target: $125 → $185
Current: $188.68
Upside: -1.95%
Bruker
Jun 8, 2026
Maintained: Buy
Price Target: $55 → $65
Current: $61.64
Upside: +5.45%
Tempus AI
Jun 1, 2026
Maintained: Hold
Price Target: $60 → $50
Current: $60.27
Upside: -17.04%
Agilent Technologies
May 27, 2026
Maintained: Buy
Price Target: $180
Current: $130.69
Upside: +37.73%
10x Genomics
May 12, 2026
Maintained: Hold
Price Target: $17 → $20
Current: $39.01
Upside: -48.73%
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $25.94
Upside: +15.65%
Danaher
May 11, 2026
Reiterated: Buy
Price Target: $245
Current: $197.93
Upside: +23.78%
Mettler-Toledo International
May 11, 2026
Rated: Hold
Price Target: $1,413 → $1,200
Current: $1,308.43
Upside: -8.29%
May 8, 2026
Reiterated: Buy
Price Target: $260 → $265
Current: $279.32
Upside: -5.13%
May 8, 2026
Rated: Buy
Price Target: $130 → $135
Current: $167.98
Upside: -19.63%
May 8, 2026
Maintained: Buy
Price Target: $35 → $30
Current: $18.30
Upside: +63.93%
May 7, 2026
Reiterated: Buy
Price Target: $120 → $125
Current: $120.35
Upside: +3.86%
May 6, 2026
Maintained: Hold
Price Target: $96 → $90
Current: $113.76
Upside: -20.89%
May 6, 2026
Maintained: Buy
Price Target: $180 → $165
Current: $142.40
Upside: +15.87%
May 6, 2026
Rated: Hold
Price Target: $330 → $345
Current: $379.29
Upside: -9.04%
Apr 30, 2026
Maintained: Hold
Price Target: $12 → $8
Current: $10.32
Upside: -22.48%
Apr 29, 2026
Maintained: Buy
Price Target: $60 → $45
Current: $40.10
Upside: +12.22%
Apr 24, 2026
Maintained: Buy
Price Target: $710 → $600
Current: $523.44
Upside: +14.63%
Apr 13, 2026
Rated: Hold
Price Target: $190 → $160
Current: $230.69
Upside: -30.64%
Nov 5, 2025
Maintained: Hold
Price Target: $14 → $16
Current: $17.93
Upside: -10.76%
Oct 29, 2025
Reiterated: Buy
Price Target: $255
Current: $207.04
Upside: +23.16%
Aug 9, 2024
Maintained: Hold
Price Target: $6 → $5
Current: $4.35
Upside: n/a